We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.8B
AUM Growth
+$485M
Cap. Flow
-$250M
Cap. Flow %
-2.12%
Top 10 Hldgs %
39.85%
Holding
1,230
New
34
Increased
603
Reduced
253
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 73.1%
2 Technology 4.03%
3 Financials 3.16%
4 Industrials 2.98%
5 Healthcare 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEDP icon
976
Medpace
MEDP
$16.6B
$19K ﹤0.01%
227
MRTX
977
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$19K ﹤0.01%
250
+26
+12% +$2.44K
GBT
978
DELISTED
Global Blood Therapeutics, Inc.
GBT
$19K ﹤0.01%
382
+24
+7% +$1.25K
ARWR icon
979
Arrowhead Research
ARWR
$12.1B
$17K ﹤0.01%
599
TDOC icon
980
Teladoc Health
TDOC
$1.6B
$17K ﹤0.01%
+250
New +$16.5K
GRFS
981
Grifois
GRFS
$5.32B
$16K ﹤0.01%
805
-69
-8% -$1.48K
IMMU
982
DELISTED
Immunomedics Inc
IMMU
$16K ﹤0.01%
1,214
GHDX
983
DELISTED
Genomic Health, Inc.
GHDX
$16K ﹤0.01%
235
ARGX icon
984
argenx
ARGX
$56.3B
$15K ﹤0.01%
136
+4
+3% +$541
CLPR
985
Clipper Realty
CLPR
$46.5M
$15K ﹤0.01%
1,500
LOGI icon
986
Logitech
LOGI
$15.3B
$15K ﹤0.01%
360
RARE icon
987
Ultragenyx Pharmaceutical
RARE
$2.68B
$15K ﹤0.01%
358
WNS
988
DELISTED
WNS Holdings
WNS
$15K ﹤0.01%
250
-150
-38% -$9.16K
MYOK
989
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$15K ﹤0.01%
290
CRSP icon
990
CRISPR Therapeutics
CRSP
$4.65B
$14K ﹤0.01%
348
+16
+5% +$765
EVH icon
991
PUT
Evolent Health
EVH
$445M
$14K ﹤0.01%
500
-1,500
-75% -$10.8K
HALO icon
992
Halozyme
HALO
$9.73B
$14K ﹤0.01%
922
IOVA icon
993
Iovance Biotherapeutics
IOVA
$2.22B
$14K ﹤0.01%
785
ICPT
994
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$14K ﹤0.01%
205
ARNA
995
DELISTED
Arena Pharmaceuticals Inc
ARNA
$14K ﹤0.01%
315
FOLD
996
DELISTED
Amicus Therapeutics
FOLD
$13K ﹤0.01%
1,622
+70
+5% +$760
MYGN icon
997
Myriad Genetics
MYGN
$527M
$13K ﹤0.01%
466
SPB icon
998
Spectrum Brands
SPB
$2.04B
$13K ﹤0.01%
+243
New +$12.7K
XLRN
999
DELISTED
Acceleron Pharma
XLRN
$13K ﹤0.01%
329
PTLA
1000
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$13K ﹤0.01%
494
+72
+17% +$2.02K

Similar funds

Daiwa Securities Group's Q3 2019 Portfolio in Review

As of Q3 2019, Daiwa Securities Group held 1,230 positions worth $11.8B, up 4.3% from $11.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Daiwa Securities Group's Q3 2019 filing shows 34 new, 603 increased, 253 reduced and 43 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M. The largest sale was Public Storage, an estimated $190M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 72% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q3 2019 buy was State Street SPDR S&P 500 ETF Trust: 42,579 shares worth $12.6M.
  • Daiwa Securities Group added most to Realty Income in Q3 2019, an estimated $211M increase.
  • Daiwa Securities Group's biggest Q3 2019 reduction was Public Storage, cutting an estimated $190M.
  • Daiwa Securities Group fully exited Coupa Software Incorporated in Q3 2019, selling an estimated $4.17M.
  • Daiwa Securities Group's ten largest holdings make up 40% of its $11.8B portfolio in Q3 2019.
  • Daiwa Securities Group opened 34 new positions and closed 43 in Q3 2019.
  • Daiwa Securities Group's portfolio value rose 4.3% quarter-over-quarter to $11.8B.

Based on Daiwa Securities Group's 13F filing for Q3 2019, filed 4 Nov 2019.